Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C3 | P42330 | 1/20 | 0.65 |
| ▸ | SRD5A2 | P31213 | 3/20 | 0.55 |
| ▸ | CA12 | O43570 | 2/20 | 0.54 |
| ▸ | CA1 | P00915 | 2/20 | 0.54 |
| ▸ | CA2 | P00918 | 2/20 | 0.54 |
| ▸ | CA9 | Q16790 | 2/20 | 0.54 |
| ▸ | CA7 | P43166 | 1/20 | 0.54 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.54 |
| ▸ | TTR | P02766 | 1/20 | 0.53 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | LTA4H | P09960 | 1/20 | 0.50 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.50 |
| ▸ | BAX | Q07812 | 1/20 | 0.50 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.49 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.48 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.47 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.47 |
| ▸ | CA6 | P23280 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5374451 | 0.89 | PARP10 (0.56) | AKR1C3SRD5A2CA12CA1CA2 | |
| SCHEMBL5747830 | 0.88 | AKR1C3 (0.74) | AKR1C3SRD5A2TTRMEN1KMT2A | |
| SCHEMBL1768785 | 0.88 | AKR1C3 (0.74) | AKR1C3SRD5A2TTRMEN1KMT2A | |
| SCHEMBL710275 | 0.83 | CA12 (0.59) | AKR1C3CA12CA1CA2CA9 | |
| SCHEMBL11579816 | 0.82 | LTA4H (0.65) | AKR1C3CA1CA2MEN1KMT2A | |
| SCHEMBL5712250 | 0.82 | LTA4H (0.65) | AKR1C3CA1CA2MEN1KMT2A | |
| SCHEMBL851606 | 0.82 | PARP15 (0.55) | AKR1C3SRD5A2CA12CA1CA2 | |
| SCHEMBL12604615 | 0.82 | SMN1; SMN2 (0.54) | AKR1C3MEN1KMT2ALTA4HNR1H2 | |
| SCHEMBL14811923 | 0.80 | AKR1C3 (0.62) | AKR1C3SRD5A2CA1CA2TTR | |
| SCHEMBL28363894 | 0.80 | HCAR1 (0.69) | AKR1C3CA12CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7196214-B2 | Process for arylamine production | XEROX CORPORATION (US) | 2007-03-27 | — | — | US | claimed |
| US-20060111582-A1 | Process for arylamine production | XEROX CORPORATION (US) | 2006-05-25 | — | — | US | claimed |
| US-9149019-B2 | Method of eliminating cat urine odor | JMR, LC (US) | 2015-10-06 | — | — | US | disclosed |
| US-20130323194-A1 | METHOD OF ELIMINATING CAT URINE ODOR | CO2 TECHNOLOGIES, INC. (US) | 2013-12-05 | — | — | US | disclosed |
| EP-2459554-B1 | SUBSTITUTED BENZAMIDE DERIVATIVES AS GLUCOKINASE (GK) ACTIVATORS | CADILA HEALTHCARE LTD (IN) | 2013-09-18 | — | — | EP | disclosed |
| WO-2011013141-A2 | SUBSTITUTED BENZAMIDE DERIVATIVES AS GLUCOKINASE (GK) ACTIVATORS | CADILA HEALTHCARE LIMITED (IN) | 2011-02-03 | — | — | WO | disclosed |
| US-7196214-B2 | Process for arylamine production | XEROX CORPORATION (US) | 2007-03-27 | — | — | US | disclosed |
| US-20070066170-A1 | CO2 GENERATING ABSORBENT PADS | CO2 TECHNOLOGIES, INC. (US) | 2007-03-22 | — | — | US | disclosed |
| US-7189666-B2 | CO2 generating absorbent pads | CO2 TECHNOLOGIES (US) | 2007-03-13 | — | — | US | disclosed |
| US-7160939-B2 | Preservatives; mixture of carbon dioxide in polymer matrix; mixture containing citric acid, calcium carbonate and low density polyethylene | CO2 TECHNOLOGIES, INC. | 2007-01-09 | — | — | US | disclosed |
| US-20060111582-A1 | Process for arylamine production | XEROX CORPORATION (US) | 2006-05-25 | — | — | US | disclosed |
| WO-2005005520-A2 | ACTIVE MASTERBATCH FOR PRODUCTION OF CO2 GENERATING MASTERBATCH | CO2 TECHNOLOGIES, INC. (US) | 2005-01-20 | — | — | WO | disclosed |
| US-20050001204-A1 | Active masterbatch for production of CO2 generating masterbatch | CO2 TECHNOLOGIES, INC. (US) | 2005-01-06 | — | — | US | disclosed |
| WO-2004110876-A2 | CO2 GENERATING ABSORBENT PADS | CO2 TECHNOLOGIES, INC. (US) | 2004-12-23 | — | — | WO | disclosed |
| US-20040247750-A1 | CO2 generating absorbent pads | CO2 TECHNOLOGIES, INC. | 2004-12-09 | — | — | US | disclosed |
| US-6797235-B2 | Device and methods for modifying an atmosphere | CO2 TECHNOLOGIES, INC. | 2004-09-28 | — | — | US | disclosed |
| WO-2004022112-A1 | DEVICE AND METHODS FOR MODIFYING AN ATMOSPHERE | CO2 TECHNOLOGIES, INC. (US) | 2004-03-18 | — | — | WO | disclosed |
| US-20040047760-A1 | Device and methods for modifying an atmosphere | LONGER SHELF LIFE, LLC | 2004-03-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060111582-A1 | Process for arylamine production | AOC2, UFM1, TYR | AKR1C3 2668/4885SRD5A2 2466/4885CA12 4463/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.